Denver Investment Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,321
Closed -$828K 511
2016
Q4
$828K Hold
10,321
0.04% 262
2016
Q3
$823K Sell
10,321
-100
-1% -$8.07K 0.04% 282
2016
Q2
$813K Sell
10,421
-535
-5% -$38.1K 0.04% 294
2016
Q1
$603K Hold
10,956
0.03% 316
2015
Q4
$677K Hold
10,956
0.03% 319
2015
Q3
$691K Hold
10,956
0.03% 310
2015
Q2
$801K Hold
10,956
0.03% 317
2015
Q1
$717K Buy
10,956
+160
+1% +$10.6K 0.02% 386
2014
Q4
$702K Hold
10,796
0.02% 376
2014
Q3
$649K Hold
10,796
0.02% 374
2014
Q2
$748K Hold
10,796
0.02% 379
2014
Q1
$706K Hold
10,796
0.02% 391
2013
Q4
$669 Hold
10,796
0.02% 406
2013
Q3
$579K Sell
10,796
-3,200
-23% -$165K 0.01% 439
2013
Q2
$639K Buy
+13,996
New +$607K 0.01% 425

Other funds holding STJ

Denver Investment Advisors's STJ Position: Q1 2017 in Review

Denver Investment Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,321 shares — an estimated $828K sold.

Denver Investment Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $828K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Denver Investment Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Denver Investment Advisors sold 10,321 St Jude Medical shares in Q1 2017, an estimated $828K.
  • Denver Investment Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Denver Investment Advisors's St Jude Medical position peaked at $828K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Denver Investment Advisors's 13F filing for Q1 2017, filed 5 May 2017.